Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)

China · Delayed Price · Currency is CNY

16.00

-1.40 (-8.05%)

Aug 24, 2026, 3:04 PM CST

-30.77% (1Y)

Market Cap	7.43B -32.7%
Revenue (ttm)	1.88B -31.3%
Net Income	-129.70M
EPS	-0.27
Shares Out	464.54M
PE Ratio	n/a
Forward PE	18.18
Dividend	0.22 (1.30%)
Ex-Dividend Date	Jun 2, 2026

Volume	20,243,368
Open	16.99
Previous Close	17.40
Day's Range	15.66 - 17.12
52-Week Range	15.47 - 26.29
Beta	0.83
Analysts	Strong Buy
Price Target	26.79 (+67.44%)
Earnings Date	Aug 24, 2026

About SHE:300482

Guangzhou Wondfo Biotech Co.,Ltd, an in vitro diagnostics company, engages in the research and development, production, market, sale, and service of vitro diagnostic products in China and internationally. The company offers rapid test kits for COVID-19, drug of abuse, tumor marker, infectious disease, fertility, blood/serum/plasma test, and sexually transmitted diseases; immunofluorescence platform for detecting cardiac, thyroid, rheumatoid arthritis, sex hormone, anemia, gastroenterology, hypertension, thrombus, tumor, inflammation, diabetes, ... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 1992

Employees 2,443

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 300482

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 4 analysts, the average rating for 300482 stock is "Strong Buy." The 12-month stock price target is ¥26.79, which is an increase of 67.44% from the latest price.

Price Target

¥26.79

(67.44% upside)

Analyst Consensus: Strong Buy

Stock Forecasts